Lycopodium Limited
LYOPF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $334 | $345 | $324 | $229 |
| % Growth | -3.1% | 6.4% | 41.6% | – |
| Cost of Goods Sold | $26 | $32 | $244 | $186 |
| Gross Profit | $308 | $312 | $80 | $42 |
| % Margin | 92.1% | 90.7% | 24.8% | 18.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $146 | $128 | $116 | $87 |
| SG&A Expenses | $146 | $128 | $19 | $16 |
| Sales & Mktg Exp. | $0 | $0 | -$97 | -$71 |
| Other Operating Expenses | $109 | $121 | $5 | -$10 |
| Operating Expenses | $255 | $249 | $23 | $6 |
| Operating Income | $53 | $64 | $57 | $36 |
| % Margin | 15.9% | 18.5% | 17.6% | 15.9% |
| Other Income/Exp. Net | $7 | $6 | -$3 | $11 |
| Pre-Tax Income | $61 | $70 | $61 | $39 |
| Tax Expense | $18 | $19 | $18 | $12 |
| Net Income | $42 | $51 | $47 | $27 |
| % Margin | 12.6% | 14.7% | 14.4% | 11.9% |
| EPS | 1.06 | 1.28 | 1.18 | 0.68 |
| % Growth | -17.2% | 8.5% | 73.5% | – |
| EPS Diluted | 1.06 | 1.28 | 1.18 | 0.68 |
| Weighted Avg Shares Out | 40 | 40 | 40 | 40 |
| Weighted Avg Shares Out Dil | 40 | 40 | 40 | 40 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $3 | $2 | $1 |
| Interest Expense | $0 | $1 | $1 | $1 |
| Depreciation & Amortization | $7 | $7 | $6 | $6 |
| EBITDA | $68 | $76 | $68 | $46 |
| % Margin | 20.3% | 22.2% | 21.1% | 20% |